27935268|t|Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter
27935268|a|Morphine shows large interindividual variability in its pharmacokinetics; however, the cause of this has not been fully addressed. The variability in morphine disposition is considered to be due to a combination of pharmacogenetic and physiological determinants related to morphine disposition. We previously reported the effect of organic cation transporter (OCT1) genotype on morphine disposition in pediatric patients. To further explore the underlying mechanisms for variability arising from relevant determinants, including OCT1, a physiologically based pharmacokinetic (PBPK) model of morphine was developed. The PBPK model predicted morphine concentration-time profiles well, in both adults and children. Almost all of the observed morphine clearances in pediatric patients fell within a twofold range of median predicted values for each OCT1 genotype in each age group. This PBPK modeling approach quantitatively demonstrates that OCT1 genotype, age-related growth, and changes in blood flow as important contributors to morphine pharmacokinetic (PK) variability.
27935268	0	16	Characterization	T052	C1880022
27935268	20	32	Contributing	T052	C1880177
27935268	33	40	Factors	T169	C1521761
27935268	44	55	Variability	T077	C2827666
27935268	59	67	Morphine	T109,T121	C0026549
27935268	68	77	Clearance	T201	C1382187
27935268	86	99	PBPK Modeling	T062	C0201734
27935268	117	133	OCT1 Transporter	T116,T123	C0291786
27935268	134	142	Morphine	T109,T121	C0026549
27935268	171	182	variability	T077	C2827666
27935268	190	206	pharmacokinetics	T169	C0031328
27935268	269	280	variability	T077	C2827666
27935268	284	292	morphine	T109,T121	C0026549
27935268	293	304	disposition	T039	C0678755
27935268	349	364	pharmacogenetic	T169	C0031328
27935268	369	382	physiological	T169	C0205463
27935268	383	395	determinants	T169	C1521761
27935268	407	415	morphine	T109,T121	C0026549
27935268	416	427	disposition	T039	C0678755
27935268	466	492	organic cation transporter	T116,T123	C0291786
27935268	494	498	OCT1	T116,T123	C0291786
27935268	500	508	genotype	T032	C0017431
27935268	512	520	morphine	T109,T121	C0026549
27935268	521	532	disposition	T039	C0678755
27935268	536	545	pediatric	T080	C1521725
27935268	546	554	patients	T101	C0030705
27935268	590	600	mechanisms	T169	C0441712
27935268	605	616	variability	T077	C2827666
27935268	639	651	determinants	T169	C1521761
27935268	663	667	OCT1	T116,T123	C0291786
27935268	671	686	physiologically	T169	C0205463
27935268	693	721	pharmacokinetic (PBPK) model	T062	C0201734
27935268	725	733	morphine	T109,T121	C0026549
27935268	753	763	PBPK model	T062	C0201734
27935268	774	782	morphine	T109,T121	C0026549
27935268	802	810	profiles	T081	C0237801
27935268	825	831	adults	T100	C0001675
27935268	836	844	children	T100	C0008059
27935268	873	881	morphine	T109,T121	C0026549
27935268	882	892	clearances	T201	C1382187
27935268	896	905	pediatric	T080	C1521725
27935268	906	914	patients	T101	C0030705
27935268	979	983	OCT1	T116,T123	C0291786
27935268	984	992	genotype	T032	C0017431
27935268	1001	1010	age group	T100	C0027362
27935268	1017	1030	PBPK modeling	T062	C0201734
27935268	1073	1077	OCT1	T116,T123	C0291786
27935268	1078	1086	genotype	T032	C0017431
27935268	1088	1106	age-related growth	T040	C0018270
27935268	1123	1133	blood flow	T039	C0232338
27935268	1147	1159	contributors	T098	C1257890
27935268	1163	1171	morphine	T109,T121	C0026549
27935268	1172	1187	pharmacokinetic	T169	C0031328
27935268	1189	1191	PK	T169	C0031328
27935268	1193	1204	variability	T077	C2827666